RG
GILD icon

Redmile Group’s Gilead Sciences GILD Stock Holding History

Redmile Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,288,846
Closed -$133M – 91
2020
Q4 		$133M Sell
2,288,846
-581,116
-20% -$35.1M 1.61% 20
2020
Q3 		$181M Buy
+2,869,962
New +$199M 3.33% 9
2015
Q1 		– Sell
-368,615
Closed -$34.7M – 59
2014
Q4 		$34.7M Buy
+368,615
New +$38.1M 3.78% 10
2014
Q1 		– Sell
-647,287
Closed -$48.6M – 58
2013
Q4 		$48.6M Buy
647,287
+117,487
+22% +$8.18M 6% 1
2013
Q3 		$33.3M Buy
+529,800
New +$31.7M 5.01% 4

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Redmile Group's GILD Position: Q1 2021 in Review

Redmile Group sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 2,288,846 shares — an estimated $133M sold.

Redmile Group first reported a position in GILD in Q3 2013 and held it in 5 quarters. The position peaked at $181M in Q3 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Redmile Group reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Redmile Group sold 2,288,846 Gilead Sciences shares in Q1 2021, an estimated $133M.
  • Redmile Group first reported a position in Gilead Sciences in Q3 2013 and held it in 5 quarters.
  • Redmile Group's Gilead Sciences position peaked at $181M in Q3 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Redmile Group's 13F filing for Q1 2021, filed 17 May 2021.